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Abstract Core–shell magnetosensitive nanocomposites
(NC) based on single-domain magnetite (Fe3O4, core), with
a shell consisting of hydroxyapatite (HA) and cytotoxic
drug doxorubicin (DOX) layers have been synthesized. The
processes of DOX adsorption on Fe3O4/HA surface from
physiologic solution have been studied. DOX release into
saline was found to decrease with growing of its quantity
on NC surface. It has been determined that cytotoxic
influence and antiproliferative activity of Fe3O4/HA/DOX
NC with respect to Saccharomyces cerevisiae cells are
characteristic for interaction of these cells with a free form
of doxorubicin. Magnetic liquids containing Fe3O4/HA/
DOX NC stabilized by sodium oleate and polyethylene
glycol were prepared and investigated. It is shown that
using the ensemble of Fe3O4 carriers as a superparamag-
netic probe, the Langevin’s paramagnetism theory, and the
values of density of nanocomposite constituents, one can
evaluate the size parameters of their shell, which has been
corroborated by independent measurements of specific
surface area of nanostructures and kinetic stability of the
corresponding magnetic liquids. The obtained results may
be useful for development and optimization of novel forms
of magnetocarried medical remedies of targeted delivery
and adsorbents based on nanocomposites of superparam-
agnetic core–shell type with multilevel nanoarchitecture, as
well as for determination and control of the size parameters
of its components.
Keywords Magnetite  Doxorubicin adsorption 
Magnetite/hydroxyapatite/doxorubicin nanocomposites 
Magnetic liquids  Dry residues  Size parameters of
nanostructure
Introduction
Magnetic nanoparticles are widely used for the preparation
of novel multifunctional therapeutic and diagnostic agents
for different fields of medicine [1–3], including oncology.
Conjugation of nanoparticles with corresponding antibody
provides nanoparticles with the ability to recognize and
‘‘mark’’ specific microbiological objects, cell populations,
microorganisms, and so on. On this basis, the concept has
been substantiated for chemical construction of magne-
tosensitive nanocomposites with multilevel hierarchical
architecture, characterized with functions of ‘‘nanoclinics’’
[2] and biomedical nanorobots [3–5] (recognition of
microbiological objects in biological environments; the
aimed delivery of drugs to target cells and organs using an
external magnetic field and deposition; complex chemo-,
immuno-, neutron capture, real-time hyperthermic therapy
and diagnostics).
To produce magnetosensitive multifunctional
nanocomposites (NC), considerable interest of researchers
is drawn by magnetite (Fe3O4)/hydroxyapatite (HA)
nanostructures of core–shell type, characterized with a
unique set of physical, chemical, and biological properties,
the ability to create on their basis magnetic liquids (ML)
containing anticancer remedies for different functional
destination, including cytotoxic drug, anthracycline
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antibiotic doxorubicin (DOX) [6–17]. In this regard, the
urgent task is to study the characteristics of the processes of
adsorptive immobilization of DOX on the surface of
Fe3O4/HA nanocomposites and its release into the saline,
which is used to create ML for medical purposes, while
maintaining biological activity of the cytotoxic drug.
It has been shown [18] that for a magnetite-based
polydisperse colloidal ML the coordination of experimen-
tal and theoretical magnetization curves is possible when
assuming that Fe3O4 particles have complex magnetic
structure, namely, a low-magnetic surface layer with
thickness h1 *0.83 nm (the lattice constant of magnetite at
300 K is 0.824 nm). Emergence of the said layer is
attributed to chemical interaction of a particle with a sta-
bilizing surfactant [19]. In [11, 20], it was found that the
calculations of magnetization curve for ML based on sin-
gle-domain Fe3O4 in the framework of Langevin’s para-
magnetism theory coordinate satisfactorily with the
experimental results in assumption that saturation magne-
tization of magnetite particles depends on their sizes, and
from experimentally measured distributions of the
nanoparticles in ensemble one can calculate the magneti-
zation curve for ML based on them.
An important issue is to find the size distribution for
ensemble of superparamagnetic nanoparticles with com-
plex shell structure from experimental measurements of the
magnetization curve. Its successful resolution could open
the way for determination of size parameters of nanoar-
chitecture elements that make multicomponent shell
structure of the nanocomposite, built on superparamagnetic
nanosized carriers, including those in the composition of
magnetic liquids.
Therefore, from the above, it can be argued that investi-
gations of the possibility of using approaches applied in [11,
20], based on the use of Langevin’s paramagnetism theory,
for the description of nanocomposites with superparamag-
netic cores and complex shell structures of different chemi-
cal nature and magnetic liquids based on them, are urgent.
The aim of this work is to investigate the DOX adsorption
on the surface of magnetite/hydroxyapatite nanostructures,
to synthesis bioactive nanocomposites magnetite/hydrox-
yapatite/doxorubicin of core–shell type and ML based on
them, to study the magnetic properties of nanocomposites
and liquids, to analyze the results using Langevin’s param-
agnetism theory, and to determine the size parameters of
multicomponent shell structure of the nanocomposites.
Experimental
Synthesis of initial magnetite, magnetite/hydroxyapatite
nanocomposites, their properties and parameters, doxoru-
bicin adsorption calculation technique are described in
[11]. In this work, we used Fe3O4 and Fe3O4/HA samples
with the specific surface area Ssp *110 and
100 ± 5 % m2/g, respectively. Presence of HA shell did
not practically change the magnetic properties [21] of
initial magnetite (the nanocomposite core).
Investigation of nanomaterials biocompatibility was
carried out by studying their influence on cell viability of
baker’s yeast Saccharomyces cerevisiae [22, 23] with the
help of Goryaev chamber using optical microscopy (bio-
logical microscope of Bresser Erudit type), and methylene
blue dye by registration of concentration change for cells
growing at the temperature of 22 C in suspensions con-
taining nanocomposites, yeast cells, minimal synthetic
nutrient medium (MSM) [24], saline (PS). Numerically
viability (K) was evaluated by the formula: K = M1/
(M1 ? M2) 9 100 %, where M1 is a number of living cells,
M2 is a number of dead cells. The data obtained was
compared to the results of control samples studies.
Bioactivity of NC Fe3O4/HA modified with DOX was
evaluated from their cytotoxic influence on S. cerevisiae
cells [25, 26] and a decrease in cell proliferation rate [24].
These effects are, in particular, due to participation of
doxorubicin in redox cyclic reactions and a corresponding
increase in quantity of free radical molecules, to induction
of oxidative stress, and to cell cycle delay in G1- and
S-phase. The concentration of cells (n, mL-1) was calcu-
lated by the formula of Goryaev chamber:
n = N 9 2.5 9 105, where N is a number of cells above a
large square of the chamber.
Investigation of isotherm of DOX adsorption on the sur-
face of Fe3O4/HA NC was performed as follows. Samples
(g) of Fe3O4/HA NC of 30 mg were mixed with DOX
solutions (V = 5 mL) of different concentration. DOX
adsorption was carried out in saline (PS) for 2 h in dynamic
mode at room temperature and pH = 7.0. The quantity of the
substance adsorbed on the surface of nanocomposites was
determined by measuring DOX concentration in the contact
solutions before and after adsorption. The concentration was
measured with the help of a spectrophotometer Spectrometer
Lambda 35 UV/Vis Perkin Elmer Instruments at
k = 480 nm using a calibration graph. In this work the
lyophilized preparation DOXORUBICIN-TEVA (Pharma-
chemie BV, The Netherlands) was used.
To study the time dependences of DOX adsorption on
the surface of Fe3O4/HA NC, as well as to study the iso-
therms, we used the samples (30 mg) of Fe3O4/HA
nanocomposite, which were mixed with DOX solutions in
saline (V = 5 mL) of varying concentration, DOX
adsorption was carried out in dynamic regime using a
shaker at room temperature. The quantity of the substance
adsorbed on the surface of nanocomposites was determined
by measuring DOX concentration in contact solutions in
fixed time (from 30 min to 24 h).
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Calculation of the hydroxyl groups concentration on the
HA surface in Fe3O4/HA nanocomposite was determined
by thermogravimetric analysis using a derivatograph
Q-1500.
Results and discussion
Adsorption studies
Doxorubicin [27] is the antitumor antibiotic agent of
anthracycline type, widely used in modern oncotherapy.
The mechanism of action is interaction with DNA, for-
mation of free radicals, and direct influence on cell mem-
branes with suppression of nucleic acids synthesis. It is
characterized by an appreciable antiproliferative effect.
The DOX absorption spectrum measured in a physio-
logical liquid environment is shown in Fig. 1.
The spectrum has several maxima: 204, 233, 254, 290,
480 cm-1, a slope angle of the line of calibration graph for
doxorubicin in the saline environment was optimal for the
wavelengthk = 480 nm (Fig. 1a), at which we carried out the
quantitative measurements of doxorubicin concentration.
Analysis of the isotherm of DOX adsorption on the
surface of Fe3O4/HA NC (Fig. 2) shows that increase in
equilibrium DOX concentration does not lead to adsorption
saturation of the surface of Fe3O4/HA adsorbent. Concavity
(S-similarity) of an initial part of isotherm relatively to the
concentration axis and lack of saturation in the investigated
range of equilibrium concentrations can be attributed to the
polymolecular nature of adsorption and low porosity of the
nanocomposite surface. In addition, S-similarity of iso-
therm can be caused to some extent by co-adsorption of
sodium chloride because DOX adsorption was performed
from saline.
Distribution coefficient (E, mL/g) of doxorubicin
between the surface of nanocomposite and solution was
366.8 mL/g at A = 91.7 mg/g.
Upon studies of DOX adsorption on the surface of
Fe3O4/HA NC as function of time (Fig. 3), it was revealed
that during the first 2 h 60–70 % of the substance is
adsorbed, and for 24 h the adsorption was almost complete
(93–97 %). And this applies to the entire range of the
investigated DOX concentrations. The dependence of the
extraction extent (R, %) of doxorubicin on concentration of
solutions and adsorption time is given in Table 1.
The results of studies on the dependence of desorption
(AD, mg/g) on time and the percentage of desorbed sub-
stance (AD, %) are given in Fig. 4 and Table 2. Experi-
mental dependencies of desorption on time indicate that the
doxorubicin release decreases with increasing its quantity
on the surface of NC. When the quantity of adsorbed DOX
is 20–50 mg/g, 80–60 % of DOX, respectively, is des-
orbed, whereas at large quantities of adsorbed DOX
(100–150 mg/g) the release almost do not occur. This sit-
uation can be explained by the peculiarities of interaction
and the emergence of sufficiently strong bonds between the
Fig. 1 Absorption spectrum of doxorubicin in PS environment.
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Fig. 2 Isotherm of doxorubicin adsorption on the surface of Fe3O4/
HA NC
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Fig. 3 Time dependence of DOX adsorption on the surface of Fe3O4/
HA NC in PS. Initial concentration of DOX solutions C, mg/mL: 1
0.13, 2 0.26, 3 0.32, 4 0.52, 5 0.64, 6 1.04
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specific functional groups on HA surface and doxorubicin
molecules: hydroxyl and carbonate groups of Fe3O4/HA
NC surface can form strong hydrogen bond with hydroxyl
and amino groups of DOX; upon the desorption, in samples
with lower concentration of DOX, the drug is desorbed
faster through partial dissociation of hydrogen bonds [28].
The basic amount of DOX is desorbed during the first
20 min for all the investigated concentrations.
Biocompatibility and bioactivity of nanocomposites
Biocompatibility of Fe3O4/HA NC is a known fact [3–11].
In this paper, biocompatibility and bioactivity of the pro-
duced samples was monitored by their effect on viability of
baker’s yeast S. cerevisiae cells [11].
In the study of bioactivity of the original drug doxoru-
bicin, we revealed experimentally that its solution in saline
at the concentration of 0.5 mg/mL resulted in almost total
death of yeast cells (95 %) for 3.5 days. In the technique
for determination of cytotoxicity, it is accepted to use IC50
dose at which there is a death of *50 % of the cells [29].
Therefore, to test bioactivity, a quantity of Fe3O4/HA/DOX
nanocomposite material (*20 mg) with immobilized
doxorubicin (*50 mg/g), that was used to form a sus-
pension, was chosen from the data of Fig. 4 and Table 2 in
calculation that the concentration of released DOX in
research suspensions was *0.25 mg/mL.
Fifteen samples in total were investigated, five
in each series
1. suspension of yeast cells (initial concentration n0 &
2.5 9 107 mL-1) in PS with MSM (Fig. 5a);
2. suspension of yeast cells (initial concentration n0 &
2.5 9 107 mL-1) in PS with MSM, containing 20 mg
of Fe3O4/HA NC;
3. suspension of yeast cells (initial concentration n0 &
3.5 9 107 mL-1) in PS with MSM, containing 20 mg
of Fe3O4/HA/DOX NC.
All the samples contained 1.3 mL of PS (0.9 % NaCl) and
1 mL of MSM. The samples of series 1 and 2 were used for
control and comparison, and series 3—for studies on
bioactivity of Fe3O4/HA/DOX NC.
Research data analysis shows that in the yeast suspen-
sions (n0 & 2.5 9 10
7 mL-1) in the PS with MSM (control
series of type 1) there is a characteristic for yeast [30] cell
division that leads to an increase in their concentration in
16 h twice (5 9 107 mL-1). Further rate of their repro-
duction slowed (possibly because of nutrient reduction). In
3.5 days their concentration was *108 mL-1. The viabil-
ity of yeast cells in the experiments of series 1 was not
significantly changed and reached *98–99 %.
Investigation of suspensions of type 2 control series
showed rather active division by which the yeast concen-
tration in 16 h was *6.5 9 107 mL-1, and in 3.5 days, as
in the previous case, reached *108 mL-1 (Fig. 5b). Cell
viability, as in the previous case, at all stages of the series 2
samples study was *98–99 %. These data indicate bio-
compatibility of Fe3O4/HA NC with respect to yeast cells
under the experiment conditions.
Table 1 Extraction extent of doxorubicin (R) on the surface of
Fe3O4/HA NC depending on the concentration of solutions and
adsorption time (t)
C0, mg/mL t, min
30 135 300 1380 1620
R, %
0.13 53.8 73.1 88.5 97.0 97.0
0.26 46.2 69.2 86.5 95.8 97.7
0.32 50.0 65.6 84.4 95.6 97.2
0.52 46.2 57.7 77.0 92.3 95.2
0.64 53.1 64.0 79.7 93.8 96.1
1.04 49.0 59.6 69.2 80.8 87.5
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Fig. 4 DOX desorption (FD) from Fe3O4/HF/DOX NC surface in PS
vs time (t) at different initial amounts of immobilized DOX
Table 2 Dependence of DOX (AD) desorption from Fe3O4/HA/DOX
NC surface in PS on time (t) at different initial amounts (A) of
immobilized DOX
A, mg/g t, min
20 60 180 400
AD, %
21.0 83.8 84.3 84.3 84.8
42.3 76.4 76.6 76.8 77.0
51.9 61.5 62.1 62.4 62.6
82.5 11.6 11.5 12.1 12.7
102.5 7.0 6.1 8.3 8.7
151.7 2.2 2.3 2.3 2.4
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Upon the studies of series 3 sample suspensions, a sig-
nificant inhibition of cell proliferation was revealed
(Fig. 5c). So, the concentration of yeast cells in the
beginning of the experiment was *3.5 9 107 mL-1 and
was practically not changed for 16 h, only in 3.5 days their
number increased up to *4 9 107 mL-1. During the
study, the quantity of dead cells in the samples of series 3
(Fig. 5c) was about 10 %.
Thus, analyzing the results of experiments of series 1
and 2 (Fig. 5b) and comparing them to the data of series 3
(Fig. 5c), we can conclude that Fe3O4/HA/DOX
nanocomposites have cytotoxic influence on S. cerevisiae
cells and reduce the rate of their proliferation.
It should be noted that the observed features of mag-
netosensitive NC Fe3O4/HA/DOX influence on yeast cells
are characteristic for the interaction of these cells with the
free form of doxorubicin [24–26].
Synthesis of magnetic liquids
In the next stage of research, samples of the three types of
magnetic liquids based on saline (ML1–3) were synthe-
sized: ML1 - Fe3O4/sodium oleate (Na ol.)/polyethylene
glycol (PEG) ? PS, ML2 - Fe3O4/HA/Na ol./PEG ? PS,
ML3 - Fe3O4/HA/DOX/Na ol./PEG ? PS. Fe3O4
nanoparticles, as well as Fe3O4/HA NC and Fe3O4/HA/
DOX NC particles were stabilized by sodium oleate [31]
and polyethylene glycol. It is known that PEG prevents
adsorption interactions of components of a liquid with
proteins [32], which is important in medical applications of
magnetic liquids. For stabilization of the NP and NC sur-
face in the ML composition, the sodium oleate samples of
weight m were calculated taking into account the concen-
tration of hydroxyl groups on the surface of magnetite and
hydroxyapatite. The calculation was performed using the
formula: m = BMg, where B is the concentration of
hydroxyl groups (2.2 mmol/g on the surface of initial
nanosized magnetite and 1.8 mmol/g on the surface of
Fe3O4/HA nanocomposite, as determined from the data of
thermogravimetric analysis using a derivatograph Q–
1500), M is the molecular weight of sodium oleate
(304 g/mol), g is a sample weight of Fe3O4 or NC. Addi-
tional modifying with PEG-2000 was carried out in
dynamic mode using a shaker; the amount of polymer was
10–15 % of the weight of Fe3O4 NP or nanocomposite
sample.
Study of magnetic and structural properties
of nanocomposites in composition of magnetic
liquids
Further researches are based on using the ensemble of
superparamagnetic carriers as a probe for determination of
parameters and control of nanostructures with complex
construction, in particular, in composition of the magnetic
liquids [11, 20, 33].
Implementation of the said approach can be achieved
using the method of magnetic granulometry [34], based on
the comparison of the experimental magnetization curve to
Langevin’s curve at the given laws of size distribution of
particles and their magnetic parameters, including satura-
tion magnetization of the particles and the thickness of
‘‘demagnetized layer’’.
To analyze the magnetization curve of ML containing
superparamagnetic nanoparticles, a known equation [35]
was applied [11]:
MðHÞ
uqMs
¼
Pk
i¼1
niðdi  2h1Þ3L MsHkBT p6 ðdi  2h1Þ
3
 
Pk
i¼1
nid
3
i
; ð1Þ
where M (H) is the magnetization of ML in magnetic field
of strength H; Ms is the saturation magnetization of a bulk
magnetite; uq is the volumetric concentration of solid
phase in ML, defined by the density of ML; di, ni is the
average diameter and quantity of Fe3O4 NP in the i interval
of the diameter variation row; k is the number of intervals;
h1 is the thickness of ‘‘demagnetized layer’’ of magnetite;
Fig. 5 Typical images of fragments of Goryaev chamber with yeast
cells: in beginning of studies (a), after interaction of yeast cells with
Fe3O4/HA NC (b), after interaction of yeast cells with Fe3O4/HA/
DOX NC (c). The interaction time is 3.5 days, T *300 K, the
concentration of cells: f 2.5 9 107 mL-1, b 1 9 108 mL-1,
c 3 9 107 mL-1
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L(n) : cthn - 1/n is the Langevin function; kB is the
Boltzmann constant; T is the temperature.
(a) Determination of the size distribution of ensemble of
nanosized magnetite particles and the thickness of
their demagnetized layer in terms of the shape of
magnetization curves of magnetic liquid.
The ensemble of Fe3O4 particles that are characterized
by the sizes of 3–23 nm being in superparamagnetic state,
has non-hysteresis demagnetization curve, and therefore,
zero values of coercive force (Hc) and residual magneti-
zation (Mr) [11]. These features of magnetization are
mainly observed in experiment also for samples of ML
based on nanocomposites Fe3O4/HA/DOX/Na ol./
PEG ? PS (ML3) (Fig. 6a).
The specific saturation magnetization rs of typical
ensembles of Fe3O4 NP synthesized for research in this
paper was 62.6 ± 2.5 % Gs cm3/g (Fig. 6b, the upper
insertion). In the study of static magnetic characteristics
(the measurement time was *100 s), Fe3O4 NP or dry
residues (DR) of magnetic liquids were distributed in the
matrix of paraffin (to prevent interparticle interaction)
under condition mDR/mp *0.1 (mDR—weight of DR, mp—
weight of paraffin). Calculation times of Neel’s relaxation
of magnetic moment of Fe3O4 NP with diameters of
3–22 nm are (10-9–102) s, respectively.
According to the experimental curve (Fig. 6a), the
coercive force (Hc) of ML3 is equal to (2 ± 0.5) Oe. The
samples of Fe3O4 NP and DR3 of ML3, distributed in
paraffin, are characterized by Hc 89.7 Oe and 90.0 Oe,
respectively (Fig. 6b). The availability of coercive force in
the investigated samples in a liquid state, probably, is due
to the presence of a small number of aggregates, joint by
dipole–dipole interaction, and in paraffin matrices—a small
number of Fe3O4 NP with diameter[22 nm.
The upper insertion in Fig. 6a shows the diameter dis-
tribution of Fe3O4 NP, obtained in experiment by statistical
processing (a program Get Data Graph Digitizer 2.24) of
TEM images of initial magnetite (1), and lognormal
diameter distribution (2), calculated for the same ensemble
using a probability density function, similar to [11]. The
average diameter value d0 = (Rnidi)/N and the standard
deviation (s) of diameter of Fe3O4 NP for a choice of
volume N = 274 was 10.77 nm (s = 3.083 nm), logarithm
of diameter: 2.33 (slnd = 0.298), logarithm of volume: 6.37
(slnV = 0.894). For mathematical expectation of Fe3O4
particle diameter M(d) and logarithm of diameter M(lnd),
the correlation is just: M(d) = exp[M(lnd) ? (rlnd)
2/2],
where rlnd is the standard deviation of logarithm of a
particle diameter [36]. The value of thickness of ‘‘demag-
netized’’ surface layer h1 of Fe3O4 NP, calculated accord-
ing formula (1) was *0.83 nm.
Figure 7 shows a model of Fe3O4/HA/DOX/Na ol./PEG
NC particle with a multilayer shell in which: d = ds ? 2h1
is the diameter of a spherical magnetite particle; ds is the
diameter of the area of Fe3O4 NP with rs which is the
characteristic for a bulk magnetite (&92 emu/g at 300 K);
h1 is the thickness of ‘‘demagnetized’’ layer of Fe3O4
particles; h2, h3, h4 are the thickness of spherical layers of
modifier (HA), drug (DOX) and stabilizer (Na ol./PEG),
respectively.
Using the model (Fig. 7), in terms of the results of
experimental measurements and ensemble parameters
-10 -5 0 5 10
-9
-6
-3
0
3
6
9
-10 -5 0 5 10
-60
-30
0
30
60
σ
(e
m
u/
g)
H(kOe)
NP Fe3O4
Hc = 89,7 Oe
-0,3 0,0 0,3
-3
0
3
σ
(e
m
u/
g)
H(kOe)
σ 
(e
m
u/
g)
H(kOe)
DR3
(b)
(a)
Fig. 6 Hysteresis loops: a ML3 (for insertions: the top 1, 2,
histograms of experimental and lognormal (2.33, 0.298) distribution
of Fe3O4 NP by diameters, respectively; the lower ones, TEM images
(scale 50 nm) of magnetite nanoparticles ensemble and initial part of
hysteresis loop of ML3); b DR3 in paraffin matrix (for insertions: the
top, hysteresis loop of Fe3O4 NP; the bottom, initial part of the loop of
DR3)
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calculation for nanoparticles of magnetite and dry residues
of magnetic liquid of corresponding composition, the shell
layers sizes of Fe3O4/HA/DOX/Na ol./PEG nanostructure
were determined.
In [11] it has been shown that for ensembles of
nanoparticles of ‘‘core–shell’’ type, under condition of
cores to be in a superparamagnetic state, formula (1)
practically unequivocally binds the size distribution of
Fe3O4 NP in ensemble with a shape of hysteresis curve.
Taking into account that in conditions of magnetic satu-
ration the Langevin function L(n) ? 1, and in DR a vol-
umetric concentration of solid phase *1, formula (1) can
be written as
MNCPMs
MNPMs
¼
hqNCPMirNCPMs
R1
0
VNCPMf ðVNCPMÞdV
hqNPMirNPMs
R1
0
VNPMf ðVNPMÞdV
; ð2Þ
where Ms
NCPM, Ms
NPM are the saturation magnetization of
ensembles of particles of NC (NCPM) and Fe3O4, respec-
tively; \qNCPM[, \qNPM[ are the average density of
ensembles of particles of NC and Fe3O4, respectively;
rs
NCPM, rs
NPM are the specific saturation magnetization of
ensembles of particles of NC and Fe3O4, respectively;
f(VNCPM), f(VNPM) are the probability density functions for
the volumes of ensembles of particles of nanocomposite
and magnetite, respectively; VNCPM, VNPM are the volume
of a particle of NC and Fe3O4, respectively.
(b) Determination of thickness of the layer of combined
stabilizer (Na ol./PEG)
The synthesized samples of initial Fe3O4 and ML1
composed of Fe3O4/Na ol./PEG ? PS were dried at room
temperature. The mass proportion of magnetite in the dry
residue of ML1 (DR1) was experimentally defined as
aFe3O4
exp = rs
DR1/rs
NPM ± 5 %, and calculated by the formula
acalcFe3O4 ¼
tFe3O4qFe3O4
qNCPMh i
; ð3Þ
where vFe3O4 =
P
nidi
3/
P
ni(di ? 2d)
3 is the volume frac-
tion of magnetite in the sample; d = h2 ? h3 ? h4 is the
thickness of the shell; qFe3O4 is the density of magnetite,
\qNCPM[ is the average density of the ensemble of NC
particles, which was found from the formula
qNCPMh i ¼
Pk
i¼1
niqNCPMiðdi þ 2dÞ3
Pk
i¼1
niðdi þ 2dÞ3
ð4Þ
The density of nanocomposite particles of i interval qNCPMi
in composition of DR1–3 was determined by formulas (5.1–
5.3):
q12i ¼ a2q1 þ 1  a2ð Þq2; where a2 ¼
di
di þ 2h2
 3
; ð5:1Þ
q123i ¼ a3q12i þ 1  a3ð Þq3; where a3
¼ di þ 2h2
di þ 2h2 þ 2h3
 3
; ð5:2Þ
q1234i ¼ a4q123i þ 1  a4ð Þq4; where a4
¼ di þ 2h2 þ 2h3
di þ 2h2 þ 2h3 þ 2h4
 3
ð5:3Þ
and q1, q2, q3, q4 are the density of magnetite, HA, DOX
and Na ol./PEG, respectively; qi
12, qi
123, qi
1234 are the
density of a particle of i interval of NC Fe3O4/HA, Fe3O4/
HA/DOX and Fe3O4/HA/DOX/Na ol./PEG, respectively.
For calculations, we used the values q1 & 5.19 g/cm
3 [37],
q2 & 2.71 g/cm
3 [28], q3 & 1.00 g/cm
3, q4 & 1.13 g/cm
3
[33]). We considered that the size distribution of Fe3O4 NP
of the initial ensemble and its dry residues was identical.
Specific surface area of the ensemble of NC particles
was determined by the formula
Scalksp ¼ 6
Pk
i¼1
niðdi þ 2dÞ2
Pk
i¼1
qNCPMiðdi þ 2dÞ3
: ð6Þ
According to the model (Fig. 7) in a particle of DR1
only h4 shell is filled (h2, h3 = 0). The results of
experimental measurements and calculations of parame-
ters of ensemble of NP Fe3O4 and DR1 are shown in
Table 3.
Fig. 7 Model of a particle of NC with a multilayer shell. It is marked:
d = ds ? 2h1 is the diameter of a spherical Fe3O4 NP; ds is the
diameter of the area of Fe3O4 NP with rs, that is characteristic for a
bulk magnetite; h1 is the thickness of the ‘‘demagnetized’’ surface
layer of Fe3O4 NP; h2, h3, h4 are the thickness of the modifying layer
(HA), drug (DOX), and combined stabilizer (Naol./PEG) in NC
structure, respectively
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As shown in Table 3, thickness of the shell of combined
stabilizer Na ol./PEG in composition of dry residue of
magnetic liquid Fe3O4/Na ol./PEG ? PS is (3.4 ± 0.1)
nm.
(c) Determination of the thickness of HA layer
To determine the thickness of HA layer we studied the
ensemble of NP Fe3O4 and ML2 composed of Fe3O4/HA/
Na ol./PEG ? PS obtained on its basis, the samples were
dried at room temperature, dry residue DR2 was obtained
and their parameters were investigated by the technique
described above. The results are shown in Table 4.
As shown in Table 4, the found value of thickness of
hydroxyapatite layer h2 in the structure of Fe3O4/HA/Na
ol./PEG is 3.5 ± 0.3 nm, which in our view is satisfacto-
rily consistent with the value of *4 nm, determined by an
independent technique in studies of Fe3O4/HA nanocom-
posites by photoelectron spectroscopy method [11]. The
obtained data may indicate reliability of the results of
determination of shell parameters in complex nanoarchi-
tecture of multifunctional magnetosensitive
nanocomposites.
(d) Determination of the thickness of DOX layer
The ensemble of magnetite nanoparticles and ML3
composed of Fe3O4/HA/DOX/Na ol./PEG ? PS obtained
on their basis, were dried at room temperature. The dried
samples Fe3O4 and dry residue DR3 were studied, as in the
previous cases. The research results are given in Table 5.
According to the data of Table 5, the found value of
thickness of the layer of medical drug doxorubicin h3 in the
structure of Fe3O4/HA/DOX/Na ol./PEG is 2.0 ± 0.3 nm.
(e) Study of sedimentation stability of magnetic liquids
The investigated ML are nanoheterogeneous systems,
where diffusion fluxes of particles dominate over
sedimentation ones. Over a long period of time (years) in
monodisperse sols, the fluxes become equal and a state of
diffusion-sedimentation equilibrium (DSE) is set, at which
the distribution of particles on height of a vessel is sub-
jected to the hypsometric law [37]:
vh=v0 ¼ exp 
Vcpðqcp  qlcÞgh
kBT
 
; ð7Þ
where mh, m0 are the concentrations of particles at height
h and at the level of bottom of a vessel, respectively; Vcp,
qcp are the volume and density of colloidal particles,
respectively; qlc is the density of a liquid carrier; g is the
acceleration of gravity.
The height at which concentration of particles varies in e
times, characterizes the thermodynamic sedimentation
stability (TDS) of a colloidal system [37] (hypsometric
height L). From Eq. (7) it follows that
L ¼ kBT
Vcpðqcp  qlcÞg
¼ 6kBT
pðd þ 2dÞ3ðhqNCPMi  qlcÞg
; ð8Þ
where \qNCPM[ is the mean density of a nanocomposite
particle with diameter of core d and thickness of shell d,
calculated by formulas (5.1–5.3).
In polydisperse systems, DSE is set for each fraction of
particles. Time of setting DSE (tb) in ML was calculated by
the technique given in [33]: we used formula tb = L0
2/\D[,
where \D[= (1/N)
P
kBT/[3pg(di ? 2d)] is the average
diffusion coefficient; L0 = kBT/[\VNCPM[ (\qNCPM[-
qlc)g] is the average hypsometric height; g is the dynamic
viscosity, determined for the concentrated ML by a labo-
ratory viscometer (the time of leakage of the fluid through a
glass capillar with diameter of 0.2 mm was &300 s); the
value g of diluted ML, according to experimental data [18],
was calculated by Einstein formula: g/g0 = 1 ? 5u/2,
where g0 is the dynamic viscosity of the liquid carrier (g0
of PS is approximately equal to 0.890 mPa s at the
Table 3 Results of experimental measurements and calculation of parameters of ensemble of NP Fe3O4 and DR1
Experimental values Calculated values
Sample d0, nm rs, Gs cm
3/g (%) aFe3O4
exp (%) Ssp
exp, m2/g (%) h4, nm \qNCPM[, g/cm
3 (%) aFe3O4
calc Ssp
cal, m2/g
Fe3O4 10.8 62.6 ± 2.5 1.00 ± 5 107.0 ± 5 0 5.19 ± 1 1.00 107.0
DR1 10.8 36.6 ± 2.5 0.58 ± 5 161.0 ± 5 3.4 ± 3 2.07 ± 1 0.58 161.0
The value of\qNCPM[was calculated by formulas (4)–(5.1–5.3), aFe3O4
calc —by formula (3). h4 value was found, at which aFe3O4
calc = aFe3O4
exp . In
terms of the obtained h4 and formulas (5.1–5.3)–(6), Ssp
calc was determined
Table 4 Results of experimental measurements and calculation of parameters of ensemble of NP Fe3O4 and DR2
Sample Experimental values Calculated values
d0, nm rs, Gs cm
3/g (%) aFe3O4
exp (%) Ssp
exp, m2/g (%) h2, nm h4, nm \qNCPM[, g/cm
3 (%) aFe3O4
calc Ssp
cal, m2/g
Fe3O4 10.8 62.6 ± 2.5 1.00 ± 5 107.0 ± 5 0 0 5.19 ± 1 1.00 107.0
DR2 10.8 13.2 ± 2.5 0.21 ± 5 114.0 ± 5 3.5 ± 3 3.4 ± 3 2.07 ± 1 0.20 114.6
230 J Nanostruct Chem (2016) 6:223–233
123
temperature of 25 C). The estimated values tb in ML1–3
are nine years and more. The experimental value of L for
ML3 is L
exp = 2.4 ± 8 % cm.
Using the found parameters of Fe3O4/HA/DOX/Na
ol./PEG nanostructure in composition of magnetic liq-
uid, the dependencies of hypsometric height (Fig. 8,
curve 1) and specific surface area of DR (curve 2) on
thickness h3 of DOX layer were plotted for the model
magnetic liquid of ML3 type, in which Fe3O4/HA/DOX/
Na ol./PEG NC was characterized by the fixed size of
the core and layers of hydroxyapatite and combined
stabilizer (dFe3O4 NP = 10.8 nm, h2 = 3.5 nm, h4 =
3.4 nm). Calculation dependence L(h3) was built by
formula (8), Ssp(h3)—(9):
Ssp ¼ 6qNCPMðd þ 2dÞ
ð9Þ
The value\qNCPM[was obtained by the formulas (5.1–
5.3).
Dependence L(h3), shown in Fig. 8, curve 1, is typical
for the colloidal systems [37]. The experimental value of
L for ML3 (L
exp = 2.4 ± 8 % cm) corresponds to
h3 = 2.2 ± 8 % nm.
Dependence Ssp(h3) given in Fig. 8 (curve 2) has a
maximum caused by that Ssp is a complex function of
qNCPM and (d ? 2d). Its position (h3cr) can be found ana-
lytically by equating to zero the expression dSsp/dd (the
criterion for finding thickness of the shell, which corre-
sponds to the maximal specific surface area of the core–
shell structure Ssp). Ordinate corresponding to the experi-
mental value Ssp
exp = 120 ± 3 % for DR3 (Table 5), twice
crosses the calculated dependence Ssp with abscissas
h3 = 1.94 nm and h3 = 5.0 nm. The value h3 = 5.0 nm
contradicts the data of magnetic measurements (Table 5)
and the value obtained by Lexp (Fig. 8, curve 1).
So, using three independent experimental methods for
measurement of rs, L, Ssp, we obtained three values of the
thickness of doxorubicin layer h3 in the structure of Fe3O4/
HA/DOX nanocomposite: 2.0 nm (Table 5), 2.2 nm
(Fig. 8, curve 1), 1.94 nm (Fig. 8, curve 2), respectively.
The found values h3 are rather close, which shows their
reliability.
We note that analysis of the sizes of superparamagnetic
iron oxide nanoparticles coated with a layer of carboxy-
dextran, which are applied as contrast agents in magnetic
resonance imaging (a commercial product Resovist and SH
U555C) using a magnetization curve and images of
ensembles of particles, obtained by transmission electron
microscopy, has been performed in [38].
The results of experimental investigations and calcula-
tions given in this paper, their testing by different ways and
comparison suggest that using ensembles of magnetic
carriers as a superparamagnetic probe and Langevin’s
paramagnetism theory, one can evaluate the sizes of the
components of complex shell structure of nanocomposites.
The obtained data may be useful in optimizing chemical
composition, structure and properties of new magnetic
liquids and adsorbents containing magnetosensitive
nanocomposites with complex construction of shell [39,
40].
Conclusions
The processes of DOX adsorption on Fe3O4/HA NC sur-
face from solution in physiologic liquid were studied. It
was determined that an increase in equilibrium
Table 5 Results of experimental measurements and calculation of parameters of magnetite nanoparticles ensemble and dry ML3 residues
Experimental values Calculated values
Sample d0,
nm
rs, Gs cm
3/g
(%)
aFe3O4
exp
(%)
Ssp
exp, m2/g
(%)
h2, nm
(%)
h3, nm
(%)
h4, nm
(%)
\qNCPM[, g/cm
3
(%)
aFe3O4
calc Ssp
cal,
m2/g
Fe3O4 10.8 62.6 ± 2.5 1.00 ± 5 107 ± 3 0 0 0 5.19 ± 1 1.00 107.0
DR3 10.8 9.9 ± 2.5 0.16 ± 5 120 ± 3 3.5 ± 3 2.0 ± 3 3.4 ± 3 1.74 ± 1 0.15 120.1
0 2 4 6
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Fig. 8 Calculation dependences: hypsometric height L (curve 1) and
specific surface area Ssp of DR (curve 2) on the thickness h3 of DOX
layer for the model magnetic liquid of ML3 type, in which Fe3O4/HA/
DOX/Na ol./PEG NC is characterized by the fixed size of the core and
layers of hydroxyapatite and combined stabilizer (dFe3O4
NP = 10.8 nm, h2 = 3.5 nm, h4 = 3.4 nm)
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concentration of DOX within the studied concentration
range does not lead to adsorption saturation of the surface
of Fe3O4/HA adsorbent. It was revealed that release of
DOX into saline decreases with growing of its quantity on
NC surface.
Magnetosensitive Fe3O4/HA/DOX NC were synthe-
sized. It has been determined that cytotoxic influence and
antiproliferative activity of NC with respect to S. cerevisiae
cells are typical for interaction of these cells with a free
form of doxorubicin.
Magnetic liquids containing Fe3O4/HA/DOX NC stabi-
lized by sodium oleate and polyethylene glycol were pro-
duced and investigated. Using the ensemble of Fe3O4
carriers as a superparamagnetic probe, Langevin’s param-
agnetism theory, the values of density of nanocomposite
constituents, the size parameters of their shell were eval-
uated, which was corroborated by independent measure-
ments of specific surface area of nanostructures and kinetic
stability of the corresponding magnetic liquids. The
obtained results may be used for the development of novel
forms of magnetocarried medical remedies for targeted
delivery and adsorbents based on nanocomposites of
superparamagnetic core–shell type with multilevel
nanoarchitecture, as well as for determination, control, and
optimization of the size parameters of its components.
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